Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Analysis of Oral Microbiota in Herpetiform Aphthous Ulcers Patients
Purpose:
To examine the microbiota in the oral mucosa and saliva of patients with herpetiform aphthous ulcers (HAU) and compare it with healthy individuals.
Materials And Methods:
16S rRNA sequencing was employed to analyze the oral mucosal bacterial communities of healthy individuals (healthy controls) and HAU patients (ulcerated sites, healthy sites, and healed ulcer sites).
Results:
Species richness in patients with HAU was statistically significantly lower than in healthy individuals. At the phylum level, the abundance of Firmicutes in the healthy sites of HAU patients was lower, while that of Proteobacteria was higher compared to healthy controls. In the ulcerated sites, the abundance of Firmicutes diminished, and the abundance of Proteobacteria increased relative to the healthy sites. In the healed ulcer sites, the abundance of these two phyla had partially recovered but had not yet reached the level of healthy sites in the ulcer phase. At the genus level, the abundance of Streptococcus in the healthy sites of HAU patients was lower than that in healthy controls, whereas Haemophilus_D was higher. In the ulcerated sites, the abundance of Streptococcus decreased, while the abundances of Neisseria and Haemophilus_D increased compared to the healthy sites. In the healed ulcer sites, the abundance of these three bacterial genera recovered to levels close to those in healthy sites during the ulcer phase. LEfSe analysis indicated that o_Enterobacterales_A, f_Pasteurellaceae, f_Erysipelotrichaceae, g_Bulleidia, f_Peptoniphilaceae, and g_Parvimonas were identified as biomarkers in the ulcerated sites.
Conclusion:
These findings highlight the distinct microbial signatures associated with HAU and suggest that microbial community changes may play a role in disease progression and healing.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.

